2015年ACC会议发布消息— PARTNER 1试验表明，经导管主动脉瓣置换术（TAVR）替代主动脉瓣置换术（SAVR）是可取的，尤其是对主动脉狭窄的高危患者，5年生存率没有明显差异。文章同步发表...
2015 years ACC conference news release - PARTNER 1 test showed that, transcatheter aortic valve replacement (TAVR) replacement of aortic valve replacement (SAVR) is desirable, especially for high-risk patients with aortic stenosis, 5 years survival rate has no obvious difference. The article published simultaneously...
